244 related articles for article (PubMed ID: 12667408)
1. Efficacy of recombinant tissue-type plasminogen activator thrombolysis and primary coronary stenting after acute myocardial infarction.
Chen B; Wang W; Zhao H; Hu D; Xu C; Zhao M; Lu M; Liu J; Wu C
Chin Med J (Engl); 2003 Jan; 116(1):142-4. PubMed ID: 12667408
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the clinical efficacy of recombinant tissue-type plasminogen activator thrombolysis with primary coronary stenting in acute myocardial infarction].
Chen B; Wang W; Zhao H; Zhao M; Hubayi ; Xu CD; Lu M
Zhonghua Nei Ke Za Zhi; 2002 Jan; 41(1):21-3. PubMed ID: 11940291
[TBL] [Abstract][Full Text] [Related]
3. Primary intracoronary stenting in comparison with intravenous rt-PA thrombolysis plus rescue intracoronary intervention in patients with acute myocardial infarction.
Zhang D; Cai X; Zhang R; Zhang J; Shen W
Chin Med J (Engl); 2002 Feb; 115(2):163-5. PubMed ID: 11940322
[TBL] [Abstract][Full Text] [Related]
4. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].
Mukawa H; Sone T; Tsuboi H; Kondo J; Kosokabe T; Uesugi M; Imai H
J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927
[TBL] [Abstract][Full Text] [Related]
5. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
[TBL] [Abstract][Full Text] [Related]
6. Comparison of primary balloon angioplasty with bailout stenting strategy to primary coronary stenting strategy in the treatment of patients with ST-segment elevation myocardial infarction (STEMI).
Tajstra M; Gasior M; Lekston A; Wilczek K; Hawranek M; Gierlotka M; Słonka G; Zebik T; Poloński L
Kardiol Pol; 2007 Nov; 65(11):1277-84; discussion 1285-6. PubMed ID: 18058578
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of low-dose mutant tissue-type plasminogen activator followed by planned rescue percutaneous transluminal coronary angioplasty as reperfusion therapy for acute myocardial infarction].
Tsukahara K; Kimura K; Usui T; Okuda J; Kitamura Y; Kosuge M; Sano T; Tohyama S; Nemoto T; Yamanaka O; Yoshii Y; Tochikubo O; Umemura S
J Cardiol; 2001 Mar; 37(3):143-50. PubMed ID: 11281054
[TBL] [Abstract][Full Text] [Related]
8. [A randomized multicenter trial comparing recombinant staphylokinase with recombinant tissue-type plasminogen activator in patients with acute myocardial infarction].
Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Aug; 35(8):691-6. PubMed ID: 17963623
[TBL] [Abstract][Full Text] [Related]
9. A comparative study on the effects of low dose of tPA and different regimens of intravenous urokinase in acute myocardial infarction.
Shen W; Zhang R; Zhang J; Zhang D; Zhang X; Zheng A
Chin Med J (Engl); 1999 Jan; 112(1):18-21. PubMed ID: 11593632
[TBL] [Abstract][Full Text] [Related]
10. Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction.
Goldenberg I; Matetzky S; Halkin A; Roth A; Di Segni E; Freimark D; Elian D; Agranat O; Har Zahav Y; Guetta V; Hod H
Am Heart J; 2003 May; 145(5):862-7. PubMed ID: 12766745
[TBL] [Abstract][Full Text] [Related]
11. [Early intravenous thrombolysis with recombinant tissue plasminogen activator for acute cerebral infarction].
Wang SY; Wang XL; Zeng H; Zuo Y; Hu N; Li XY; Huang F; Yu HL; Wang HY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):542-5. PubMed ID: 12971850
[TBL] [Abstract][Full Text] [Related]
12. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
[TBL] [Abstract][Full Text] [Related]
13. Procedural results, in-hospital course and six-month follow-up after rescue compared to primary stenting in acute myocardial infarction.
La Vecchia L; Martini M; Bedogni F; Righetti T; Sartori M; Vincenzi P; Vincenzi M
Ital Heart J; 2000 Jan; 1(1):50-5. PubMed ID: 10868924
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
[TBL] [Abstract][Full Text] [Related]
15. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
[TBL] [Abstract][Full Text] [Related]
16. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
17. Influence of different start time of urokinase therapy after acute myocardial infarction efficacy of thrombolysis. The Collaborative Research Group on Thrombolysis.
Chin Med J (Engl); 1997 Jan; 110(1):47-9. PubMed ID: 9594321
[TBL] [Abstract][Full Text] [Related]
18. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
[TBL] [Abstract][Full Text] [Related]
19. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
